1. Home
  2. CLSD vs FONR Comparison

CLSD vs FONR Comparison

Compare CLSD & FONR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLSD
  • FONR
  • Stock Information
  • Founded
  • CLSD 2011
  • FONR 1978
  • Country
  • CLSD United States
  • FONR United States
  • Employees
  • CLSD N/A
  • FONR N/A
  • Industry
  • CLSD Biotechnology: Pharmaceutical Preparations
  • FONR Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • CLSD Health Care
  • FONR Health Care
  • Exchange
  • CLSD Nasdaq
  • FONR Nasdaq
  • Market Cap
  • CLSD 68.4M
  • FONR 77.1M
  • IPO Year
  • CLSD 2016
  • FONR 1987
  • Fundamental
  • Price
  • CLSD $0.46
  • FONR $16.00
  • Analyst Decision
  • CLSD Hold
  • FONR
  • Analyst Count
  • CLSD 4
  • FONR 0
  • Target Price
  • CLSD $4.33
  • FONR N/A
  • AVG Volume (30 Days)
  • CLSD 12.7M
  • FONR 33.4K
  • Earning Date
  • CLSD 08-11-2025
  • FONR 05-15-2025
  • Dividend Yield
  • CLSD N/A
  • FONR N/A
  • EPS Growth
  • CLSD N/A
  • FONR N/A
  • EPS
  • CLSD N/A
  • FONR 1.28
  • Revenue
  • CLSD $3,764,000.00
  • FONR $103,018,089.00
  • Revenue This Year
  • CLSD $143.33
  • FONR N/A
  • Revenue Next Year
  • CLSD N/A
  • FONR N/A
  • P/E Ratio
  • CLSD N/A
  • FONR $12.59
  • Revenue Growth
  • CLSD N/A
  • FONR 0.29
  • 52 Week Low
  • CLSD $0.29
  • FONR $12.00
  • 52 Week High
  • CLSD $1.65
  • FONR $18.64
  • Technical
  • Relative Strength Index (RSI)
  • CLSD 34.58
  • FONR 56.41
  • Support Level
  • CLSD $0.29
  • FONR $15.85
  • Resistance Level
  • CLSD $0.62
  • FONR $16.22
  • Average True Range (ATR)
  • CLSD 0.11
  • FONR 0.32
  • MACD
  • CLSD -0.02
  • FONR -0.07
  • Stochastic Oscillator
  • CLSD 25.16
  • FONR 22.35

About CLSD Clearside Biomedical Inc.

Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing a proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina, or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.

About FONR Fonar Corporation

Fonar Corp is a United States-based company which is engaged in the business of designing, manufacturing, selling and servicing magnetic resonance imaging (MRI) scanners, which utilize MRI technology for the detection and diagnosis of human disease, abnormalities, other medical conditions, and injuries. The company operates through two segments namely Manufacturing and servicing of medical equipment; and the Management of diagnostic imaging centers, which generates a vast majority of the revenue.

Share on Social Networks: